At a glance
- Originator Hokuriku Seiyaku
- Class Antihypertensives; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia; Hypertension
Most Recent Events
- 20 May 1998 Discontinued-Preclinical for Benign prostatic hyperplasia in Japan (Unknown route)
- 20 May 1998 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
- 26 May 1997 No-Development-Reported for Benign prostatic hyperplasia in Japan (Unknown route)